Stargardt diseaseDisease1 paperMeSH D000080362Human trial1Trial sponsorsAscidian TherapeuticsCompany1 trialPhase 1/215 peopleNational Eye Institute1 trialPhase 1/255 peopleLatestLancet·15 OctHuman embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studiesNon-randomised trial in 18 peopleAge-related macular degenerationPaper
Lancet·15 OctHuman embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studiesNon-randomised trial in 18 peopleAge-related macular degenerationPaper